John joined GTCR in 2006 and is a Vice President in the Healthcare group. Prior to joining GTCR, he worked as an Analyst in the healthcare group of Citigroup Global Markets in New York. John holds an MBA with distinction from Harvard Business School and a BS in finance with highest honors from the University of Illinois. He serves on the Board of Rx30 and works closely with Cedar Gate Technologies, Cole-Parmer Instrument Company and XIFIN. John previously served as a Director of Correctional Healthcare Companies, a past GTCR investment.